Goldman Sachs
CASI icon

Goldman Sachs’s CASI Pharmaceuticals CASI Stock Holding History

Goldman Sachs’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,447
Closed -$20K – 6474
2022
Q1 		$20K Sell
2,447
-2,593
-51% -$20.4K ﹤0.01% 6411
2021
Q4 		$40K Sell
5,040
-14,959
-75% -$149K ﹤0.01% 6296
2021
Q3 		$238K Buy
19,999
+4,881
+32% +$66K ﹤0.01% 5635
2021
Q2 		$234K Buy
15,118
+8,913
+144% +$150K ﹤0.01% 5666
2021
Q1 		$149K Buy
6,205
+3,247
+110% +$91.2K ﹤0.01% 5744
2020
Q4 		$87K Sell
2,958
-14,705
-83% -$320K ﹤0.01% 5312
2020
Q3 		$271K Buy
17,663
+16,501
+1,420% +$311K ﹤0.01% 4785
2020
Q2 		$29K Sell
1,162
-1,749
-60% -$38K ﹤0.01% 5108
2020
Q1 		$59K Sell
2,911
-1,879
-39% -$44.8K ﹤0.01% 5024
2019
Q4 		$148K Buy
4,790
+1,300
+37% +$42.2K ﹤0.01% 4980
2019
Q3 		$117K Buy
3,490
+1,671
+92% +$53.6K ﹤0.01% 4940
2019
Q2 		$58K Sell
1,819
-1,524
-46% -$48.7K ﹤0.01% 5006
2019
Q1 		$96K Buy
3,343
+428
+15% +$14.9K ﹤0.01% 4932
2018
Q4 		$118K Buy
2,915
+63
+2% +$2.39K ﹤0.01% 4969
2018
Q3 		$133K Buy
+2,852
New +$199K ﹤0.01% 5044
2018
Q2 		– Sell
-17,806
Closed -$743K – 5675
2018
Q1 		$743K Buy
17,806
+15,920
+844% +$594K ﹤0.01% 4237
2017
Q4 		$61K Buy
+1,886
New +$51.2K ﹤0.01% 5890
2016
Q4 		– Sell
-2,475
Closed -$27K – 6903
2016
Q3 		$27K Sell
2,475
-543
-18% -$5.96K ﹤0.01% 6668
2016
Q2 		$35K Buy
+3,018
New +$38.1K ﹤0.01% 6540

Other funds holding CASI

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bailard
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Goldman Sachs's CASI Position: Q2 2022 in Review

Goldman Sachs sold out of CASI Pharmaceuticals (CASI) in Q2 2022, closing a stake of 2,447 shares — an estimated $20K sold.

Goldman Sachs first reported a position in CASI in Q2 2016 and held it in 19 quarters. The position peaked at $743K in Q1 2018. 24 funds tracked by Wall St. Rank hold CASI as of Q2 2022.

  • Goldman Sachs reported no remaining CASI Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Goldman Sachs sold 2,447 CASI Pharmaceuticals shares in Q2 2022, an estimated $20K.
  • Goldman Sachs first reported a position in CASI Pharmaceuticals in Q2 2016 and held it in 19 quarters.
  • Goldman Sachs's CASI Pharmaceuticals position peaked at $743K in Q1 2018.
  • 24 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q2 2022.

Based on Goldman Sachs's 13F filing for Q2 2022, filed 15 Aug 2022.